Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Sarmand (Heidelberg, Germany), S. Piel (Heidelberg, Germany), E. Brunnemer (Heidelberg, Germany), J. Waelscher (Heidelberg, Germany), M. Polke (Heidelberg, Germany), A. Warth (Heidelberg, Germany), C. Heussel (Heidelberg, Germany), M. Eichinger (Heidelberg, Germany), F. Lasistschka (Heidelberg, Germany), B. Hoegerle (Heidelberg, Germany), L. Frankenstein (Heidelberg, Germany), H. Zabeck (Heidelberg, Germany), S. Rieken (Heidelberg, Germany), F. Herth (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany). Pulmonary Lymphangiomatosis – insights into an ultra-rare disease. 2246

Member's Comments

No comment yet.

Related content which might interest you: Gaining insights into pulmonary hypertension in respiratory diseases Source: Eur Respir J 2015; 46: 1247-1250 Year: 2015 Pulmonary hypertension: a paradigm for rare pulmonary diseases Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017 Year: 2017 Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Living well with pulmonary fibrosis: new insights Source: Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway Year: 2021 Characteristics and outcomes of heritable pulmonary veno-occlusive disease due to EIF2AK4 mutations Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Pulmonary vascular disease Source: HERMES Summer School 2014 - Educational material Year: 2014 Pulmonary diseases and ageing Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine Year: 2020 Pulmonary rehabiliatation for patient with intersitual lung disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Metastatic pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 360s Year: 2003 Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives Source: Eur Respir J 2005; 26: 984-985 Year: 2005 Pulmonary hydatid disease: a unique treatment for an uncommon disease Source: Eur Respir J 2007; 30: Suppl. 51, 392s Year: 2007 Pulmonary involvement in behcet's disease Source: Eur Respir J 2002; 20: Suppl. 38, 63s Year: 2002 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 First insights from the BTS idiopathic pulmonary fibrosis (IPF) registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016